Active Ingredient History
Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abatacept (Phase 3)
Aging (Early Phase 1)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Anemia, Aplastic (Phase 1)
Anemia, Diamond-Blackfan (Phase 1)
Anemia, Refractory (Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
Apoptosis (Phase 4)
Arthralgia (Phase 3)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 4)
Asthma (Phase 2)
Autoimmune Diseases (Phase 3)
beta-Thalassemia (Phase 1/Phase 2)
Blood Glucose (Phase 2)
Cardiovascular Diseases (Early Phase 1)
Chediak-Higashi Syndrome (Phase 1)
Colitis, Ulcerative (Phase 3)
Common Variable Immunodeficiency (Phase 2)
COVID-19 (Phase 4)
Crohn Disease (Phase 3)
CTLA-4 Antigen (Phase 1/Phase 2)
Dermatomyositis (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Drug Combinations (Phase 4)
Dyskeratosis Congenita (Phase 1)
Eye Diseases (Phase 2)
Fanconi Anemia (Phase 1)
Giant Cell Arteritis (Phase 3)
Glomerulosclerosis, Focal Segmental (Phase 2)
Graft vs Host Disease (Phase 2)
Granuloma (Phase 3)
Granulomatosis with Polyangiitis (Phase 3)
Granulomatous Disease, Chronic (Phase 1)
Healthy Volunteers (Phase 1)
Heart Diseases (Phase 3)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cells (Phase 1/Phase 2)
Hepatitis, Autoimmune (Phase 1)
Hypertension (Phase 2)
Immunoglobulin G4-Related Disease (Phase 2)
Inflammation (Early Phase 1)
Kidney Transplantation (Phase 2)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Liver Cirrhosis, Biliary (Phase 4)
Lung Diseases, Interstitial (Phase 2)
Lupus Erythematosus, Systemic (Phase 2/Phase 3)
Lupus Nephritis (Phase 3)
Lymphocytosis (Phase 4)
Lymphohistiocytosis, Hemophagocytic (Phase 1)
Lymphoma (Phase 3)
Methotrexate (Phase 4)
Mucopolysaccharidosis I (Phase 1)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myasthenia Gravis (Early Phase 1)
Myelodysplastic Syndromes (Phase 3)
Myocarditis (Phase 2)
Myocardium (Phase 4)
Myositis (Phase 3)
Neoplasms (Phase 3)
Nephrosis, Lipoid (Phase 2)
Nephrotic Syndrome (Phase 2)
Neutropenia (Phase 1)
Patient Compliance (Phase 3)
Peanut Hypersensitivity (Phase 2)
Pemphigus (Phase 4)
Polychondritis, Relapsing (Phase 1)
Polymyalgia Rheumatica (Phase 3)
Polymyositis (Phase 3)
Prostatic Neoplasms (Phase 4)
Psoriasis (Phase 2)
Rheumatic Diseases (Phase 4)
Rheumatology (Phase 4)
Sarcoidosis (Phase 2)
SARS-CoV-2 (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Shwachman-Diamond Syndrome (Phase 1)
Sjogren's Syndrome (Phase 3)
Spondylarthritis (Phase 4)
Spondylitis, Ankylosing (Phase 2)
Substance Withdrawal Syndrome (Phase 3)
Takayasu Arteritis (Phase 2)
Thrombasthenia (Phase 1)
Thrombocytopenia (Phase 2)
Tissue Adhesions (Phase 1)
Urticaria (Phase 1/Phase 2)
Uveitis (Phase 2)
Vitiligo (Phase 1)
Wiskott-Aldrich Syndrome (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
